Indian government task force makes recommendations to curb drug counterfeiting

15 April 2012

Last week, a high-level task force on pharmaceutical manufacturing recommended the adoption of unique code verification technology and mobile SMS authentication for all domestic medicines produced in India. The task force, assembled by the Union Health Ministry last year, undertook research on available track and trace technologies as part of an ongoing effort by the government to curb drug counterfeiting.

The task force recommended this particular solution for track and trace which is based on its viability and affordability for implementing across the Indian pharmaceutical market. It also suggested the technology be implemented in several phases.

Nathan Sigworth, chief executive of PharmaSecure, a provider of this type of SMS mobile authentication technology in India, said: "The Union Health Ministry Task Force's recommendation of unique ID codes and mobile authentication is a great step in the fight against counterfeit medicines. The technology allows companies to protect their brands and for consumers to ensure that the medicine consumers are taking are real, not counterfeit."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical